Human CellExp™ CD45, human recombinant
LCA; LY5; B220; T200; CD45R; GP180; PTPRC
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P08575 |
---|---|
Calculated MW | 65kDa |
Gene ID | 5788 |
---|---|
Other Names | LCA; LY5; B220; T200; CD45R; GP180; PTPRC |
Gene Source | Human |
Source | HEK 293 cells |
Assay&Purity | SDS-PAGE;≥ 98% |
Recombinant | Yes |
Target/Specificity | PTPRC |
Application Notes | Reconstitute in 1X PBS to the desired protein concentration. |
Format | Lyophilized |
Storage | -20°C;Lyophilized from 0.2 µm-filtered solution in PBS. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Protein tyrosine phosphatase, receptor type C (CD45), also known as PTPRC is a member of the protein tyrosine phosphatase (PTP) family which is known for its function to serve as signaling molecules and to regulate a variety of cellular processes such as cell proliferation, differentiation, mitotic cycle and oncogenic transformation. CD45 is found expression specifically in hemotopietic cells. CD45 consists of an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains. It serves as an essential regulator of T-cell and B-cell antigen receptor signaling through either direct interaction with components of the antigen receptor complexs or by activating various Src family kinases required for the antigen receptor signaling and it also can suppress JAK kinases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.